Stormorken AT - Search Results

1

Immunohistochemistry identifies carriers of mismatch repair gene defects causing hereditary nonpolyposis colorectal cancer.

Stormorken AT, Bowitz-Lothe IM, Norèn T, Kure E, Aase S, Wijnen J, Apold J, Heimdal K, Møller P. Stormorken AT, et al. J Clin Oncol. 2005 Jul 20;23(21):4705-12. doi: 10.1200/JCO.2005.05.180. J Clin Oncol. 2005. PMID: 16034045

2

Familial endometrial cancer in female carriers of MSH6 germline mutations.

Wijnen J, de Leeuw W, Vasen H, van der Klift H, Møller P, Stormorken A, Meijers-Heijboer H, Lindhout D, Menko F, Vossen S, Möslein G, Tops C, Bröcker-Vriends A, Wu Y, Hofstra R, Sijmons R, Cornelisse C, Morreau H, Fodde R. Wijnen J, et al. Nat Genet. 1999 Oct;23(2):142-4. doi: 10.1038/13773. Nat Genet. 1999. PMID: 10508506 No abstract available.

3

[Hereditary colorectal cancer].

Stormorken AT, Apold J, Heimdal K, Møller P. Stormorken AT, et al. Tidsskr Nor Laegeforen. 1999 Oct 30;119(26):3933-6. Tidsskr Nor Laegeforen. 1999. PMID: 10592756 Review. Norwegian.

4

Prediction of a mismatch repair gene defect by microsatellite instability and immunohistochemical analysis in endometrial tumours from HNPCC patients.

de Leeuw WJ, Dierssen J, Vasen HF, Wijnen JT, Kenter GG, Meijers-Heijboer H, Brocker-Vriends A, Stormorken A, Moller P, Menko F, Cornelisse CJ, Morreau H. de Leeuw WJ, et al. J Pathol. 2000 Nov;192(3):328-35. doi: 10.1002/1096-9896(2000)9999:9999<::AID-PATH701>3.0.CO;2-2. J Pathol. 2000. PMID: 11054716

5

MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families.

Vasen HF, Stormorken A, Menko FH, Nagengast FM, Kleibeuker JH, Griffioen G, Taal BG, Moller P, Wijnen JT. Vasen HF, et al. J Clin Oncol. 2001 Oct 15;19(20):4074-80. doi: 10.1200/JCO.2001.19.20.4074. J Clin Oncol. 2001. PMID: 11600610

6

The inframe MSH2 codon 596 deletion is linked with HNPCC and associated with lack of MSH2 protein in tumours.

Stormorken AT, Müller W, Lindblom A, Heimdal K, Aase S, Lothe IM, Norèn T, Wijnen JT, Möslein G, Møller P. Stormorken AT, et al. Fam Cancer. 2003;2(1):9-13. doi: 10.1023/a:1023362205205. Fam Cancer. 2003. PMID: 14574162

7

Prediction of the outcome of genetic testing in HNPCC kindreds using the revised Amsterdam criteria and immunohistochemistry.

Stormorken AT, Müller W, Lemkemeyer B, Apold J, Wijnen JT, Fodde R, Möslein G, Møller P. Stormorken AT, et al. Fam Cancer. 2001;1(3-4):169-73. doi: 10.1023/a:1021151227983. Fam Cancer. 2001. PMID: 14574174

8

Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance.

Hendriks YM, Wagner A, Morreau H, Menko F, Stormorken A, Quehenberger F, Sandkuijl L, Møller P, Genuardi M, Van Houwelingen H, Tops C, Van Puijenbroek M, Verkuijlen P, Kenter G, Van Mil A, Meijers-Heijboer H, Tan GB, Breuning MH, Fodde R, Wijnen JT, Bröcker-Vriends AH, Vasen H. Hendriks YM, et al. Gastroenterology. 2004 Jul;127(1):17-25. doi: 10.1053/j.gastro.2004.03.068. Gastroenterology. 2004. PMID: 15236168

9

Psychological distress in women at risk of hereditary breast/ovarian or HNPCC cancers in the absence of demonstrated mutations.

Geirdal AØ, Reichelt JG, Dahl AA, Heimdal K, Maehle L, Stormorken A, Møller P. Geirdal AØ, et al. Fam Cancer. 2005;4(2):121-6. doi: 10.1007/s10689-004-7995-y. Fam Cancer. 2005. PMID: 15951962

10

Estimated prevalence of hereditary cancers and the need for surveillance in a Norwegian county, Telemark.

Stormorken AT, Hoff G, Norstein J, Bowitz-Lothe IM, Hanslien E, Grindedal E, Møller P. Stormorken AT, et al. Scand J Gastroenterol. 2006 Jan;41(1):71-9. doi: 10.1080/00365520510023891. Scand J Gastroenterol. 2006. PMID: 16373279

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

33 results

Search Page